D
Health Catalyst, Inc.
HCAT
$4.11
-$0.32-7.22%
D
Sell
8/8/2024Upgraded
Health Catalyst, Inc. (HCAT) was upgraded to D- from E+ on 8/8/2024 due to a noticeable increase in the growth index, solvency index and volatility index. Operating cash flow increased 153.92% from -$19.04M to $10.27M, earnings per share increased from -$0.5274 to -$0.3514, and EBIT increased 18.11% from -$21.96M to -$17.99M.
Health Catalyst, Inc. (HCAT) was upgraded to D- from E+ on 8/8/2024 due to a noticeable increase in the growth index, solvency index and volatility index. Operating cash flow increased 153.92% from -$19.04M to $10.27M, earnings per share increased from -$0.5274 to -$0.3514, and EBIT increased 18.11% from -$21.96M to -$17.99M.
E
Sell
2/22/2024Downgrade
Health Catalyst, Inc. (HCAT) was downgraded to E+ from D- on 2/22/2024 due to a decline in the volatility index.
Health Catalyst, Inc. (HCAT) was downgraded to E+ from D- on 2/22/2024 due to a decline in the volatility index.
D
Sell
2/5/2024Upgraded
Health Catalyst, Inc. (HCAT) was upgraded to D- from E+ on 2/5/2024 due to an increase in the volatility index and valuation index.
Health Catalyst, Inc. (HCAT) was upgraded to D- from E+ on 2/5/2024 due to an increase in the volatility index and valuation index.
E
Sell
1/19/2024Downgrade
Health Catalyst, Inc. (HCAT) was downgraded to E+ from D- on 1/19/2024 due to a decline in the valuation index.
Health Catalyst, Inc. (HCAT) was downgraded to E+ from D- on 1/19/2024 due to a decline in the valuation index.
D
Sell
12/27/2023Upgraded
Health Catalyst, Inc. (HCAT) was upgraded to D- from E+ on 12/27/2023 due to an increase in the volatility index.
Health Catalyst, Inc. (HCAT) was upgraded to D- from E+ on 12/27/2023 due to an increase in the volatility index.
E
Sell
12/12/2023Downgrade
Health Catalyst, Inc. (HCAT) was downgraded to E+ from D- on 12/12/2023 due to a decline in the volatility index.
Health Catalyst, Inc. (HCAT) was downgraded to E+ from D- on 12/12/2023 due to a decline in the volatility index.
D
Sell
3/14/2023Downgrade
Health Catalyst, Inc. (HCAT) was downgraded to D- from D on 3/14/2023 due to a decline in the valuation index.
Health Catalyst, Inc. (HCAT) was downgraded to D- from D on 3/14/2023 due to a decline in the valuation index.
D
Sell
2/23/2023Upgraded
Health Catalyst, Inc. (HCAT) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index and volatility index.
Health Catalyst, Inc. (HCAT) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index and volatility index.
D
Sell
2/8/2023Downgrade
Health Catalyst, Inc. (HCAT) was downgraded to D- from D on 2/8/2023 due to a decline in the growth index, solvency index and volatility index. Earnings per share declined from -$0.6228 to -$0.8422, operating cash flow declined 25.64% from -$9.58M to -$12.03M, and EBIT declined 19.92% from -$28.55M to -$34.23M.
Health Catalyst, Inc. (HCAT) was downgraded to D- from D on 2/8/2023 due to a decline in the growth index, solvency index and volatility index. Earnings per share declined from -$0.6228 to -$0.8422, operating cash flow declined 25.64% from -$9.58M to -$12.03M, and EBIT declined 19.92% from -$28.55M to -$34.23M.
D
Sell
5/31/2022Upgraded
Health Catalyst, Inc. (HCAT) was upgraded to D from D- on 05/31/2022.
Health Catalyst, Inc. (HCAT) was upgraded to D from D- on 05/31/2022.
D
Sell
5/13/2022Downgrade
Health Catalyst, Inc. (HCAT) was downgraded to D- from D on 5/13/2022 due to a large decline in the solvency index, total return index and volatility index. Debt to equity increased from 0.35 to 0.48, and the quick ratio declined from 5.32 to 5.06.
Health Catalyst, Inc. (HCAT) was downgraded to D- from D on 5/13/2022 due to a large decline in the solvency index, total return index and volatility index. Debt to equity increased from 0.35 to 0.48, and the quick ratio declined from 5.32 to 5.06.
D
Sell
5/5/2022Upgraded
Health Catalyst, Inc. (HCAT) was upgraded to D from D- on 5/5/2022 due to an increase in the valuation index.
Health Catalyst, Inc. (HCAT) was upgraded to D from D- on 5/5/2022 due to an increase in the valuation index.
D
Sell
4/20/2022Downgrade
Health Catalyst, Inc. (HCAT) was downgraded to D- from D on 4/20/2022 due to a substantial decline in the total return index, growth index and volatility index. Operating cash flow declined 82.37% from -$5.36M to -$9.78M, and earnings per share declined from -$0.8166 to -$0.94.
Health Catalyst, Inc. (HCAT) was downgraded to D- from D on 4/20/2022 due to a substantial decline in the total return index, growth index and volatility index. Operating cash flow declined 82.37% from -$5.36M to -$9.78M, and earnings per share declined from -$0.8166 to -$0.94.
D
Sell
1/7/2022Downgrade
Health Catalyst, Inc. (HCAT) was downgraded to D from D+ on 1/7/2022 due to a decline in the volatility index and total return index.
Health Catalyst, Inc. (HCAT) was downgraded to D from D+ on 1/7/2022 due to a decline in the volatility index and total return index.
D
Sell
12/2/2021Upgraded
Health Catalyst, Inc. (HCAT) was upgraded to D+ from D on 12/2/2021 due to an increase in the valuation index.
Health Catalyst, Inc. (HCAT) was upgraded to D+ from D on 12/2/2021 due to an increase in the valuation index.
D
Sell
11/10/2021Upgraded
Health Catalyst, Inc. (HCAT) was upgraded to D from D- on 11/10/2021 due to an increase in the valuation index.
Health Catalyst, Inc. (HCAT) was upgraded to D from D- on 11/10/2021 due to an increase in the valuation index.
D
Sell
11/8/2021Downgrade
Health Catalyst, Inc. (HCAT) was downgraded to D- from D on 11/8/2021 due to a decline in the valuation index.
Health Catalyst, Inc. (HCAT) was downgraded to D- from D on 11/8/2021 due to a decline in the valuation index.
D
Sell
5/1/2020Upgraded
Health Catalyst, Inc. (HCAT) was upgraded to D from D- on 05/01/2020.
Health Catalyst, Inc. (HCAT) was upgraded to D from D- on 05/01/2020.
D
Sell
4/3/2020Downgrade
Health Catalyst, Inc. (HCAT) was downgraded to D- from D on 4/3/2020 due to a decline in the efficiency index, valuation index and volatility index. Total capital declined 2.46% from $259.69M to $253.3M.
Health Catalyst, Inc. (HCAT) was downgraded to D- from D on 4/3/2020 due to a decline in the efficiency index, valuation index and volatility index. Total capital declined 2.46% from $259.69M to $253.3M.
D
Sell
10/17/2019None
Health Catalyst, Inc. (HCAT) was downgraded to D from U on 10/17/2019.
Health Catalyst, Inc. (HCAT) was downgraded to D from U on 10/17/2019.
NASDAQ
03/13/2025 4:00PM Eastern
Quotes delayed
